| Financial Year |
March 31 2023 |
| Monetary Funds |
790,703,229.84 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
91,917,273.03 |
| Advances to Suppliers |
9,069,987.13 |
| Other Receivables |
14,239,173.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
4,701,388.88 |
| Dividend Receivable |
-- |
| Inventories |
67,351,034.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
563,197,708.33 |
| Other Current Assets |
32,965,649.03 |
| Total Current Assets |
1,569,444,056.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
653,873,537.91 |
| Investment Properties |
259,551,259.40 |
| Fixed Assetes |
75,826,502.08 |
| Under-construction Projects |
616,278,860.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
639,512,434.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
51,995,647.70 |
| Deferred Income Tax Assets |
314,623.79 |
| Other Non-Current Assets |
1,351,493,415.39 |
| Sub-Total of Non-Current Assets |
3,963,542,609.32 |
| Total Assets |
5,532,986,665.61 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
75,788,765.71 |
| Accounts Received In Advance |
3,384,558.04 |
| Employee Compensation Payable |
92,890,569.24 |
| Taxes Payable |
7,593,642.85 |
| Interest Payable |
-- |
| Dividend Payable |
1,425,239.89 |
| Other payables |
112,707,514.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,848,194.87 |
| Other Current Liabilities |
3,436,564.62 |
| Sub-Total of Current Liabilities |
390,214,871.85 |
| Long-term Loans |
544,579,100.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,976,451.06 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
661,501,459.22 |
| Total Liabilities |
1,051,716,331.07 |
| Paid-In Capital(Or Share Stock) |
1,161,058,174.00 |
| Capital Surplus |
1,340,198,622.94 |
| Surplus Reserve |
363,066,123.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,402,536,871.88 |
| Minority Stockholder's Interest |
3,302,206.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,477,968,128.36 |
| Owner's Equity（Stockholder's Equity） |
4,481,270,334.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,532,986,665.61 |
